C

Researcher Profile

Camille Chakiba

3

Publications

310

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article Breast Cancer Research and Treatment Dec 19, 2023

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Judith Balmaña · Peter A. Fasching · Fergus J. Couch · Suzette Delaloge +143 more

10.1007/s10549-023-07165-x 18 citations

Open Access Journal Article The Lancet Oncology Nov 01, 2022

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

François-Clément Bidard · Anne-Claire Hardy-Bessard · Florence Dalenc · Thomas Bachelot +90 more

10.1016/s1470-2045(22)00555-1 266 citations

Open Access Journal Article European Journal of Cancer Jul 01, 2021

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

Karen A. Gelmon · Peter A. Fasching · Fergus J. Couch · Judith Balmaña +100 more

10.1016/j.ejca.2021.03.029 26 citations

Publication Timeline

2023

1

2022

1

2021

1

Frequent Co-Authors

Dominique SPAETH

Suzette Delaloge

Thibault de la Motte Rouge

Jacques MEDIONI

Florence Dalenc

Christelle Levy

Alain Lortholary

Jean-Sébastien Frenel

Caroline Michie